These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 12767971)

  • 1. International normalized ratio and anticoagulation.
    Theerman MR
    Arch Intern Med; 2003 May; 163(10):1242-3; author reply 1244. PubMed ID: 12767971
    [No Abstract]   [Full Text] [Related]  

  • 2. Is low-molecular-weight heparin safer than warfarin for secondary prevention of venous thromboembolism in cancer patients?
    Caine GJ; Lip GY
    Arch Intern Med; 2003 May; 163(10):1243-4; author reply 1244. PubMed ID: 12767973
    [No Abstract]   [Full Text] [Related]  

  • 3. Apparent warfarin potency inconsistencies compromise effectiveness.
    Rothschild BM
    Arch Intern Med; 2003 May; 163(10):1243; author reply 1244. PubMed ID: 12767972
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: a randomized controlled study.
    Meyer G; Marjanovic Z; Valcke J; Lorcerie B; Gruel Y; Solal-Celigny P; Le Maignan C; Extra JM; Cottu P; Farge D
    Arch Intern Med; 2002 Aug 12-26; 162(15):1729-35. PubMed ID: 12153376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulation quality and the risk of recurrence of venous thromboembolism.
    Poli D; Antonucci E; Ciuti G; Abbate R; Prisco D
    Thromb Haemost; 2007 Nov; 98(5):1148-50. PubMed ID: 18000626
    [No Abstract]   [Full Text] [Related]  

  • 6. Low-molecular-weight heparin in cancer-associated thrombosis: treatment, secondary prevention, and survival.
    Nishioka J; Goodin S
    J Oncol Pharm Pract; 2007 Jun; 13(2):85-97. PubMed ID: 17873108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practical application of the 10-mg warfarin initiation nomogram.
    Wells PS; Le Gal G; Tierney S; Carrier M
    Blood Coagul Fibrinolysis; 2009 Sep; 20(6):403-8. PubMed ID: 19521238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Possible effect low molecular weight heparin on survival time. New chances for cancer patients?].
    MMW Fortschr Med; 2003 May; 145(19):suppl 3-4. PubMed ID: 12813994
    [No Abstract]   [Full Text] [Related]  

  • 9. Prophylaxis of catheter-related thrombosis in cancer patients.
    Prandoni P
    Lancet; 2009 Feb; 373(9663):523-4. PubMed ID: 19217973
    [No Abstract]   [Full Text] [Related]  

  • 10. Anticoagulation therapy: reinforcing patient education.
    Cranwell-Bruce LA
    Medsurg Nurs; 2007 Feb; 16(1):55-8. PubMed ID: 17441633
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term anticoagulation prophylaxis following acute thromboembolism.
    Hyers TM
    Dis Mon; 2005; 51(2-3):158-65. PubMed ID: 15900268
    [No Abstract]   [Full Text] [Related]  

  • 12. Thromboembolism.
    Fitzmaurice D; Hobbs FD; McManus R
    Clin Evid; 2002 Jun; (7):199-213. PubMed ID: 12230644
    [No Abstract]   [Full Text] [Related]  

  • 13. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen.
    Douketis JD; Johnson JA; Turpie AG
    Arch Intern Med; 2004 Jun; 164(12):1319-26. PubMed ID: 15226166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-molecular-weight heparin versus oral anticoagulant therapy for the long-term treatment of symptomatic venous thromboembolism: Is there any difference in cancer-related mortality?
    Ferretti G; Bria E; Giannarelli D; Carlini P; Felici A; Mandala M; Papaldo P; Nistico C; Fabi A; Cuppone F; Gelibter A; Terzoli E; Cognetti F
    J Clin Oncol; 2005 Oct; 23(28):7248-50; author reply 7250. PubMed ID: 16192623
    [No Abstract]   [Full Text] [Related]  

  • 15. What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke?
    Kamphuisen PW; Agnelli G
    Thromb Res; 2007; 119(3):265-74. PubMed ID: 16674999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
    van Doormaal FF; Raskob GE; Davidson BL; Decousus H; Gallus A; Lensing AW; Piovella F; Prins MH; Büller HR
    Thromb Haemost; 2009 Apr; 101(4):762-9. PubMed ID: 19350123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thrombosis in spite of warfarin--what should be done?].
    Lassila R
    Duodecim; 2001; 117(24):2632-6. PubMed ID: 12183826
    [No Abstract]   [Full Text] [Related]  

  • 18. Low-molecular-weight heparin or oral anticoagulation for secondary prevention of deep vein thrombosis in cancer patients.
    Levine M
    Semin Thromb Hemost; 2003 Dec; 29 Suppl 1():9-11. PubMed ID: 14730472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venous thromboembolism in the ICU and reversal of bleeding on anticoagulants.
    DeLoughery TG
    Crit Care Clin; 2005 Jul; 21(3):497-512. PubMed ID: 15992670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-intensity versus conventional-intensity warfarin for prevention of recurrent venous thromboembolism.
    Tran HA
    N Engl J Med; 2003 Nov; 349(22):2164-7; author reply 2164-7. PubMed ID: 14658126
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.